CXCL13 and myeloid sarcoma: With regard to autoimmunity, CXCL13 elevations in the blood occur in SLE, RA, SS, MS, and MG, and are proposed biomarkers for disease activity, treatment response, and treatment targets for autoimmune disorders [30,34,80,81,82].